François-Joseph-Victor Broussais
1772-1838 · Francés · Medicina clínica
Médico militar francés y profesor cuya doctrina de la medicina fisiológica impulsó la explosión de principios del siglo XIX en el uso terapéutico de sanguijuelas en los hospitales de París y en el mundo médico francés en general.
Perfil
- Años de vida
- 1772-1838
- Nacionalidad
- French
- Época
- Siglo XIX
- Campo principal
- Medicina clínica
Afiliaciones institucionales
- École impériale de santé militaire du Val-de-Grâce, Paris (Professor of Pathology and Therapeutics)
- Hôpital militaire du Val-de-Grâce (Chief Physician)
- Académie royale de médecine, Paris (member)
Contribuciones clave
- Developed the doctrine of physiological medicine, attributing most diseases to gastrointestinal inflammation (gastroenteritis) and prescribing aggressive local bloodletting as primary therapy.
- Popularized the application of large numbers of leeches (often dozens per session, occasionally over a hundred) to the abdomen and other inflammatory sites — driving annual French leech consumption to tens of millions in the 1820s and 1830s.
- Held the chair of general pathology and therapeutics at the Val-de-Grâce military medical school, Paris, training a generation of French and foreign military physicians in his methods.
- Authored Examen de la doctrine médicale généralement adoptée (1816) and the foundational Histoire des phlegmasies ou inflammations chroniques (1808), the works that established his system.
- His clinical practice and writings were the principal driver of France's industrial-scale leech importation from Eastern Europe, Algeria, and Anatolia that nearly extirpated Hirudo medicinalis from much of its native range.
Importancia para la hirudoterapia
François-Joseph-Victor Broussais is the figure whose name is most closely associated with the peak era of medical leech use — the so-called leech mania of the 1820s and 1830s, during which French clinical medicine consumed leeches at a scale never seen before or since. The numbers are staggering: France imported and used between thirty and forty million medical leeches in 1833 alone, the majority destined for hospitals in Paris and provincial cities where Broussaisian physiological medicine had become the dominant therapeutic doctrine. Broussais himself was reported to apply fifty or more leeches in a single session for severe gastroenteritis, and his disciples extended the practice to virtually every inflammatory and febrile condition. The theoretical scaffolding for this practice was Broussais's doctrine that nearly all disease originated in localized inflammation of the gastrointestinal mucosa, which secondarily produced systemic symptoms. Therapy therefore aimed at reducing this gastrointestinal inflammation through aggressive local sanguine evacuation — leeches applied to the epigastrium being the preferred intervention because they evacuated blood from the affected territory without the systemic effects of venesection. The doctrine was wrong about pathophysiology but produced enormous quantities of clinical observation that, in retrospect, document the real effects (and harms) of intensive leech application better than any other source in the historical record. Broussais's importance to modern hirudotherapy is double-edged but essential. On one hand, his enthusiasm drove the leech-farming and leech-importing industry to a scale that supported the survival of medical leech expertise through the subsequent nineteenth-century decline; the French Ricarimpex pharmacy, founded in 1845, descends directly from this commercial infrastructure and remains today the world's principal supplier of FDA-cleared medicinal leeches. On the other hand, the abuses of the Broussaisian era — exsanguinated patients, ecologically devastated leech populations — became the cautionary tale that empowered Rudolf Virchow and the cellular-pathology generation to dismiss leech therapy as superstition. ASH treats Broussais as the cautionary patron of the field: the figure whose excesses defined both the apex of leech use and the conditions for its near-extinction.
Publicaciones clave
- Histoire des phlegmasies ou inflammations chroniques · Paris medical treatise (1808)
- Examen de la doctrine médicale généralement adoptée et des systèmes modernes de nosologie · Paris medical treatise (1816)
- De l'irritation et de la folie · Paris medical treatise (1828)
Recursos externos
Investigación influenciada
Compuestos y áreas de investigación que se remontan a las contribuciones de esta figura:
Figuras relacionadas
John Berry Haycraft
1857-1922 · Británico (escocés)
Fisiólogo de Edimburgo que descubrió la hirudina en 1884, fundando la farmacología molecular moderna de la saliva de sanguijuela.
Marie Termier
1859-1930 · Francés
Médica francesa que en 1922 publicó uno de los primeros estudios clínicos formales de la terapia con sanguijuelas para la trombosis postquirúrgica, estableciendo la metodología clínica moderna en hirudoterapia.
Andreas Michalsen
1961- · Alemán
Charité Berlin integrative medicine physician whose 2003 Annals of Internal Medicine RCT in knee osteoarthritis became the landmark trial that brought hirudotherapy into Cochrane reviews and modern integrative-medicine guidelines.
Sabine Andereya
1968- · Alemán
Cirujana ortopédica de Aachen cuyos ECAs de 2006 y 2008 en osteoartritis carpometacarpiana sintomática validaron la terapia con sanguijuelas como eficaz para la artritis de pequeñas articulaciones de la mano — la segunda indicación probada en la hirudoterapia moderna.